Similar effects were observed in the type 2 diabetic mice, indicating that the recombinant strain GM4-ΔTS-PGK1-CCT can be used as a living cell liposome to delivery polypeptide drugs, as this was the aim in this experiment. This evidence concerns the gene FLVCR2 and type 2 diabetes mellitus.